Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00936936
Title High-dose Chemotherapy for Poor-prognosis Relapsed Germ-Cell Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

germ cell cancer

Therapies

Gemcitabine

Ifosfamide

Etoposide

Melphalan

Etoposide + Ifosfamide

Docetaxel + Gemcitabine + Melphalan

Bevacizumab + Carboplatin

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.